News

Incidence of Kawasaki Disease Holding Steady


 

SAN DIEGO — Preliminary results from an ongoing surveillance of Kawasaki disease in the United States suggest that no unusual increases in cases occurred between 1998 and 2003, Ryan Maddox reported in a poster session at an international Kawasaki disease symposium.

“For the most part, the findings were consistent with those of previous studies and in line with what we'd expect,” Mr. Maddox, an epidemiologist with the division of viral and rickettsial diseases at the Centers for Disease Control and Prevention, Atlanta, told Family Practice News. “We're not seeing more cases reported, which is a good sign.”

He pointed out that while the study involved patients in 29 states, 80% of the data came from clinicians in just four states: California, Illinois, Michigan, and Virginia. “Obviously, we can't make a claim about [nationwide] incidence based on that,” he said, but added that a new case reporting form was available was available online (www.cdc.gov\ncidod\diseases\kawasaki\index.htm

Between 1998 and 2003, 1,854 cases of Kawasaki disease were reported, which represents an estimated 10% of Kawasaki disease patients nationwide. Most patients (79.9%) were younger than 5 years, and 59.8% were boys.

Nearly all the patients (99%) were hospitalized for their disease, and 97.8% received intravenous immunoglobulin. Coronary artery abnormalities were reported in 14.7% of patients, which is higher than the 10.3% reported in a surveillance study conducted between 1991 and 1993. Reasons for this increase may have to do with improved ways to detect coronary artery abnormalities since the earlier study.

“It appears that [the prevalence of] aneurysms remained fairly constant over this period,” Mr. Maddox said. “However, [coronary] dilatations have been increasing. That's something that can be picked up through echo testing, which may be better at detecting these dilatations [than before.] That could account for at least some of the increase we're seeing.”

The investigators also observed that 23.2% of patients had illness onset in February or March, while 12.4% had onset in August or September. Some suggest Kawasaki disease could caused by a virus, which could explain the increased prevalence during February and March.

Recommended Reading

Drug-Eluting Stents Meet Cost-Effectiveness Standards
MDedge Family Medicine
Poor Kidney Function Augurs Anemia in HF
MDedge Family Medicine
Encouraging Results From New Platelet Inhibitor
MDedge Family Medicine
Panel Backs Candesartan-ACE Inhibitor Combo
MDedge Family Medicine
Combo First to Improve MI Mortality in 12 Years : Dual antiplatelet therapy—aspirin plus a short course of clopidogrel—shines in two large studies.
MDedge Family Medicine
Fish Oil Supplements Touted as Alternative to Treat High Triglycerides
MDedge Family Medicine
1 in 12 MIs Present With Life-Threatening Noncardiac Condition
MDedge Family Medicine
Does furosemide decrease morbidity or mortality for patients with diastolic or systolic dysfunction?
MDedge Family Medicine
Clinical decision rules accurately predict stroke risk in atrial fibrillation
MDedge Family Medicine
Popular diets equally effective for losing weight
MDedge Family Medicine